ASCO concurs with cancer care ontario for CRC follow-up

November 15, 2013
ASCO concurs with cancer care ontario for CRC follow-up
The American Society of Clinical Oncology has endorsed Cancer Care Ontario guidelines for colorectal cancer survivor follow-up care, according to a study published online Nov. 12 in the Journal of Clinical Oncology.

(HealthDay)—The American Society of Clinical Oncology (ASCO) has endorsed Cancer Care Ontario (CCO) guidelines for colorectal cancer survivor follow-up care, according to a study published online Nov. 12 in the Journal of Clinical Oncology.

Jeffrey A. Meyerhardt, M.D., M.P.H., from the Dana-Faber Cancer Institute in Boston, and colleagues from an ASCO panel considered endorsement of the CCO Guideline on Follow-up Care, Surveillance Protocol, and Secondary Prevention Measures for Survivors of Colorectal Cancer.

The ASCO agreed with the CCO recommendations, and recommended endorsement with incorporation of qualifying statements. Surveillance should be guided by the assumed risk of recurrence and patients' functional status. For five years, medical history, physical examination, and carcinoembryonic antigen testing should be conducted every three to six months, with testing recommended in the more frequent range for patients at higher risk of recurrence. In most cases, a computed tomography scan (abdomen and chest) should be performed annually for three years. Outside of a clinical trial, scans should not be used for . One year after the initial surgery and every five years thereafter the patient should undergo surveillance colonoscopy. Colonoscopy should be performed after completion of adjuvant therapy (before one year) if it was not done before diagnosis. Maintenance of a healthy weight and an active lifestyle are recommended for secondary prevention. Surveillance tests should not be performed if the patient is not a candidate for surgery or systemic therapy due to severe comorbid conditions.

"The ASCO Panel concurred with the CCO recommendations and recommended endorsement, with the addition of several qualifying statements," the authors write.

Explore further: Adherence to cancer surveillance guidelines varies

More information: Abstract
Full Text

Related Stories

Adherence to cancer surveillance guidelines varies

March 30, 2012

(HealthDay) -- Insured breast cancer survivors have high rates of guideline-recommended recurrence testing and non-recommended metastatic testing, while only about half of colorectal cancer survivors undergo recommended surveillance ...

Overuse of surveillance colonoscopy after resection

February 1, 2013

(HealthDay)—Approximately one-third of patients with normal results on their first and second colonoscopies after undergoing curative resection for colorectal cancer undergo subsequent surveillance colonoscopies within ...

ASCO issues recommendations for promoting tobacco control

July 30, 2013

(HealthDay)—The American Society of Clinical Oncology (ASCO) has updated the 2003 recommendations on tobacco cessation and control; the policy statement has been published online July 29 in the Journal of Clinical Oncology.

ATS issues top five 'Choosing Wisely' recommendations

October 29, 2013

(HealthDay)—The top five pulmonology-related issues that physicians and patients should question have been released by the American College of Chest Physicians and American Thoracic Society (ATS) as part of the Choosing ...

SGO issues top five Choosing Wisely recommendations

November 6, 2013

(HealthDay)—The top five gynecologic oncology-related issues that physicians and patients should question have been released by the Society of Gynecologic Oncology (SGO) as part of the Choosing Wisely campaign.

Recommended for you

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.